ONCT

Latest SEC Filings & News for ONCT

2 most recent filings and news items mentioning ONCT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ONCT/news?limit=20"

Pull ONCT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJul 8, 2026Neutral

Ernst & Young endorses Oncolytics Biotech's key disclosures

Ernst & Young LLP reviewed and agreed with specific management statements in the July 8-K concerning financial condition. The auditor provides third-party verification of the MD&A prior to the SEC's review period.

View filing at SEC.gov →

OfferingJun 29, 2026Neutral

Oncotelic Therapeutics enters securities purchase agreement for $178,410

Oncotelic Therapeutics entered a securities purchase agreement with Pacific Pier Capital II, LLC to sell a promissory note. This issuance of 500,000 common stock shares indicates the company is securing external funding.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.